Author:
Garay Joseph P,Karakas Bedri,Abukhdeir Abde M,Cosgrove David P,Gustin John P,Higgins Michaela J,Konishi Hiroyuki,Konishi Yuko,Lauring Josh,Mohseni Morassa,Wang Grace M,Jelovac Danijela,Weeraratna Ashani,Sherman Baust Cheryl A,Morin Patrice J,Toubaji Antoun,Meeker Alan,De Marzo Angelo M,Lewis Gloria,Subhawong Andrea,Argani Pedram,Park Ben H
Publisher
Springer Science and Business Media LLC
Reference64 articles.
1. van de Velde CJ, Verma S, van Nes JG, Masterman C, Pritchard KI: Switching from tamoxifen to aromatase inhibitors for adjuvant endocrine therapy in postmenopausal patients with early breast cancer. Cancer Treat Rev. 2009
2. Cauley JA, Lucas FL, Kuller LH, Stone K, Browner W, Cummings SR: Elevated serum estradiol and testosterone concentrations are associated with a high risk for breast cancer. Study of Osteoporotic Fractures Research Group. Ann Intern Med. 1999, 130: 270-277.
3. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, Barbieri RL, Speizer FE: Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1998, 90: 1292-1299. 10.1093/jnci/90.17.1292.
4. Dimitrakakis C, Bondy C: Androgens and the breast. Breast Cancer Res. 2009, 11: 212-10.1186/bcr2413.
5. Lea OA, Kvinnsland S, Thorsen T: Improved measurement of androgen receptors in human breast cancer. Cancer Res. 1989, 49: 7162-7167.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献